increasing number of sepsis cases is driving the Sepsis Diagnostics Market
Technavio analyzes that the Sepsis Diagnostics Market is expected to grow at a CAGR of 8.9% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 510 million.There are various factors that contribute to the growth of the market. The global sepsis diagnostics market is experiencing significant growth due to the rising incidence of sepsis cases worldwide. Sepsis, a life-threatening condition caused by the body's response to infection, is a major health concern, particularly in developing countries. According to the World Health Organization, sepsis results in approximately 11 million deaths each year. Early and accurate diagnosis of sepsis is crucial to improve patient outcomes and reduce mortality rates. The market for sepsis diagnostics is anticipated to expand as the demand for rapid and reliable testing solutions increases. Technological advancements in sepsis diagnostics, such as point-of-care tests and biomarker-based assays, are expected to drive market growth in the coming years.
The global sepsis diagnostics market is primarily driven by the need for rapid and accurate identification of infectious agents causing sepsis, including bacterial, viral, and fungal infections. Blood culture tests remain the gold standard, offering comprehensive identification of pathogens and their antimicrobial susceptibilities. Automated blood culture systems have revolutionized this diagnostic method, reducing manual handling and contamination risks, thereby enhancing overall accuracy. Market leaders are continually innovating, introducing advanced blood culture technologies that deliver faster detection times and increased sensitivity. These advancements are essential for timely sepsis diagnosis and effective therapeutic interventions, particularly in severe cases of sepsis and septic shock.
Know which region is leading the market growth by requesting a sample report
Sepsis Diagnostics Market Segmentation
As per our research findings, here are some of the key competitors that are leading the industry
Find out what is trending in the market by accessing the free PDF report
The Sepsis Diagnostics Market encompasses various diagnostic technologies including microbiology, molecular biology, immunoassay, and next-generation sequencing (NGS) for the detection of sepsis, severe sepsis, septic shock, bacterial infections, viral infections, and fungal infections. With a rising prevalence of hospital-acquired infections (HAIs) and infection rates, there is a growing demand for rapid and accurate diagnostic tests. Point-of-care (POC) diagnostic methods, such as immunoassays and rapid test kits, are gaining popularity due to their ease of use and quick results. Infection prevention and value-based care are key drivers for the adoption of these diagnostic technologies in ICUs and other healthcare settings. Instruments, reagents, and consumables are essential components of these diagnostic technologies. Digitalization and automation are also trends in the sepsis diagnostics market, with a focus on early detection and biomarker-based diagnostics to improve patient outcomes and reduce ICU mortality.
The sepsis diagnostics market encompasses microbiology, molecular biology, immunoassay technologies, and companies specializing in the research and development or production of these diagnostic tools. According to Technavio's market analysis, the global healthcare industry, which includes the revenue generated by manufacturers and providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services, is expected to expand due to several factors. Among these drivers is the increasing prevalence of hospital-acquired infections (HAIs), which necessitates advanced diagnostic solutions for timely sepsis detection. As the global population ages, with one-quarter of the US population predicted to be over 60 years old by 2050 and Europe projected to reach a similar demographic milestone by 2030, the demand for infection prevention and diagnostic tests will continue to grow, fueling the expansion of the sepsis diagnostics market.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
